Skip to main content
VNDA logo

VNDA · Vanda Pharmaceuticals Inc. · Documents

Track VNDA — free
$3.99 +0.17 (+4.32%) Play latest call Q3 2026 earnings call transcript
Market Cap
$230.99M
Shares
60.47M
Volume · Nov 9 206K Avg daily vol (3M) 1.06M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2020
Aug 6
Quarterly report 10-Q FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $62.21M ▲ 5.3% Net income $8.71M ▼ 24.4% Diluted EPS $0.16 ▼ 23.8%
Feb 26
Annual report 10-K FY2019, ended Dec 31
Annual report for FY2019
Revenue $227.19M ▲ 17.6% Net income $115.55M ▲ 358.4% Diluted EPS $2.11 ▲ 339.6%
Showing 151–174 of 174 documents
Key facts CIK 1347178 CUSIP 921659108 13F (30d) 68 filings 52 filers Visit website Investor relations